PAVmed Inc.
PAVM
$7.75
$0.111.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.00K | 1.02M | 1.99M | 3.00M | 4.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.00K | 1.02M | 1.99M | 3.00M | 4.03M |
| Cost of Revenue | 180.00K | 1.51M | 3.13M | 4.84M | 6.40M |
| Gross Profit | -151.00K | -486.00K | -1.14M | -1.84M | -2.37M |
| SG&A Expenses | 16.57M | 22.43M | 29.79M | 36.15M | 43.53M |
| Depreciation & Amortization | 0.00 | 82.00K | 187.00K | 559.00K | 1.06M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.22M | 27.95M | 37.89M | 47.48M | 59.72M |
| Operating Income | -20.19M | -26.93M | -35.90M | -44.49M | -55.68M |
| Income Before Tax | 1.43M | 68.15M | 65.56M | 28.43M | 9.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.43 | 68.15 | 65.56 | 28.43 | 9.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.67M | 4.73M | 8.41M | 11.36M | 14.45M |
| Net Income | 3.10M | 72.88M | 73.97M | 39.79M | 24.32M |
| EBIT | -20.19M | -26.93M | -35.90M | -44.49M | -55.68M |
| EBITDA | -20.04M | -26.55M | -35.24M | -43.29M | -53.83M |
| EPS Basic | 11.10 | 212.75 | 199.08 | 82.20 | 18.99 |
| Normalized Basic EPS | -5.40 | -14.16 | -27.73 | -44.16 | -82.23 |
| EPS Diluted | -21.17 | 30.91 | 17.36 | -71.47 | -130.58 |
| Normalized Diluted EPS | -2.08 | -3.70 | -17.27 | -35.41 | -75.08 |
| Average Basic Shares Outstanding | 2.14M | 1.76M | 1.46M | 1.29M | 1.20M |
| Average Diluted Shares Outstanding | 7.47M | 8.23M | 7.94M | 6.48M | 2.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |